ArticleJournal of thoracic disease2023

C-reactive protein and lactate dehydrogenase serum levels potentially predict the response to checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Yilun Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.